Everpride Phar 1H NP dn 37.4% to RMB17mln

Everpride Biopharmaceutical Company (8019) announced its interim results for the period ended June 2001: Net profit attributable to shareholders was RMB17.101mln, down 37.37%. EPS was 3.72 cents. No second quarterly dividend was declared.

Related stock : (8019)